Comparing Factor Use and Bleed Rates in US Hemophilia A Patients Receiving Prophylaxis With 3 Different Long-Acting Recombinant Factor VIII Products

home / publications / supplement / comparing-factor-use-bleed-rates-with-3-different-long-acting-recombinant-factor-viii-products
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo